1. W. G. Hearl and M. J. Jonston, “Levels of 2′,5′-oligoadenylates in the tissues of pathogen-free mice,” in: The 2-5A System: Molecular and Clinical Aspects of the Interferon-Regulated Pathway, B. R. G. Williams and R. H. Silverman (eds.), Alan R. Liss Inc., New York, London (1985), pp. 19–24.
2. M. Esteban and E. Paez, “The 2-5A system and vaccinia virus,” in: The 2-5A System: Molecular and Clinical Aspects of the Interferon-Regulated Pathway, B. R. G. Williams and R. H. Silverman (eds.), Alan R. Liss Inc., New York, London (1985), pp. 25–34.
3. M. I. Johnston, W. G. Hearl, J. C. White, et al., “Immunochemistry, physical chemistry and biology of oligoadenylates,” in: The 2-5A System: Molecular and Clinical Aspects of the Interferon-Regulated Pathway, B. R. G. Williams and R. H. Silverman (eds.), Alan R. Liss Inc., New York, London (1985), pp. 37–45.
4. H. Sawai, K. Ishibashi, M. Itoh, and S. Watanabe, “Radioimmuno assay for 2-5A using a novel 125I-labeled 2-5A analog, and analysis of 2-5A and 2-5A synthetase activity in human plasma,” in: The 2-5A System: Molecular and Clinical Aspects of the Interferon-Regulated Pathway, B. R. G. Williams and R. H. Silverman (eds.), Alan R. Liss Inc., New York, London (1985), pp. 97–104.
5. I. V. Mykhailyk, L. I. Ostapchenko, and M. Ye. Kucherenko, “Interferon-induced system of oligoadenylate: key components and biological functions,” Ukr. Biokhim. Zh., 75, No. 3, 11–21 (2003).